Moderna, Inc. (MRNA)
28.26
+0.02
(+0.07%)
USD |
NASDAQ |
Dec 10, 09:43
Moderna Market Cap: 11.04B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 877.21B |
| Merck & Co., Inc. | 239.89B |
| Pfizer Inc. | 143.93B |
| Johnson & Johnson | 485.64B |
| Amgen, Inc. | 168.96B |
Market Cap Related Metrics
| PS Ratio | 4.903 |
| PEG Ratio | -0.0912 |
| Price to Book Value | 1.184 |
| Price | 28.26 |
| Earnings Yield | -28.53% |
| PEGY Ratio | -0.0912 |